Patents Assigned to Hemanext Inc.
  • Patent number: 11911471
    Abstract: A method for reducing hemolysis and microparticle formation during storage of pathogen reduced blood. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced hemolysis. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles. Oxygen and pathogen reduced blood compositions comprising CPAD and riboflavin having reduced hemolysis. Oxygen and pathogen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles.
    Type: Grant
    Filed: September 23, 2021
    Date of Patent: February 27, 2024
    Assignee: Hemanext Inc.
    Inventors: Samuel O. Sowemimo-Coker, Jeffrey Sutton, Tatsuro Yoshida
  • Publication number: 20230248767
    Abstract: Methods for prevention and reversal of inflammation.
    Type: Application
    Filed: January 20, 2023
    Publication date: August 10, 2023
    Applicant: Hemanext Inc.
    Inventors: Andrew DUNHAM, Tatsuro YOSHIDA, Samuel O. SOWEMIMO-COKER
  • Publication number: 20230247984
    Abstract: The present disclosure relates to Oxygen Reduction Disposable kits (ORDKit), devices and methods for the improved preservation of whole blood and blood components. The improved devices and methods for the collection of blood and blood components provide for whole blood and blood components having reduced levels of oxygen. The devices and methods provide for the rapid preparation of deoxygenated blood and blood components for storage that improves the overall quality of the transfused blood and improves health outcomes in patients.
    Type: Application
    Filed: April 7, 2023
    Publication date: August 10, 2023
    Applicant: Hemanext Inc.
    Inventors: Michael WOLF, Jancarlo SARITA, Jeffrey Karl SUTTON, Rafael CORDERO, Michael ZOCCHI, Philip KEEGAN, Narendran RENGANATHAN, Robert HARHEN
  • Publication number: 20230180741
    Abstract: The present disclosure relates to carbon dioxide permeable containers for storing blood and methods for the improved preservation of whole blood and blood components. The improved devices and methods for the collection of blood and blood components provide for whole blood and blood components having reduced levels of carbon dioxide and the elimination of the plasticizer DEHP. The devices and methods provide for the preparation of carbon dioxide depleted blood and blood components for storage that improves the overall quality of the transfused blood and improves health outcomes inpatients and reduces risks associated with DEHP. The devices and methods also provide for maintenance of low oxygen content in blood and blood components during storage. Compositions comprising a blood product and an additive solution are also disclosed.
    Type: Application
    Filed: May 12, 2021
    Publication date: June 15, 2023
    Applicant: Hemanext Inc.
    Inventor: Samuel O. SOWEMIMO-COKER
  • Publication number: 20230165896
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma.
    Type: Application
    Filed: January 9, 2023
    Publication date: June 1, 2023
    Applicant: Hemanext Inc.
    Inventors: Andrew DUNHAM, Tatsuro YOSHIDA
  • Patent number: 11638421
    Abstract: The present disclosure relates to Oxygen Reduction Disposable kits (ORDKit), devices and methods for the improved preservation of whole blood and blood components. The improved devices and methods for the collection of blood and blood components provide for whole blood and blood components having reduced levels of oxygen. The devices and methods provide for the rapid preparation of deoxygenated blood and blood components for storage that improves the overall quality of the transfused blood and improves health outcomes in patients.
    Type: Grant
    Filed: May 20, 2022
    Date of Patent: May 2, 2023
    Assignee: Hemanext Inc.
    Inventors: Michael Wolf, Jancarlo Sarita, Jeffrey Karl Sutton, Rafael Cordero, Michael Zocchi, Philip Keegan, Narendran Renganathan, Robert Harhen
  • Publication number: 20230047634
    Abstract: Method for transfusion medicine to reduce adverse events in transfusion patient populations based on underlying patient physiology.
    Type: Application
    Filed: October 28, 2022
    Publication date: February 16, 2023
    Applicant: Hemanext Inc.
    Inventors: Angelo D'ALESSANDRO, Rafael CORDERO, Andrew DUNHAM, Philip KEEGAN, Tatsuro YOSHIDA
  • Patent number: 11576931
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma. Methods for restoring mean arterial pressure to a normal range and reducing trauma adverse risks in a patient through the administration of oxygen reduced blood compositions.
    Type: Grant
    Filed: June 4, 2021
    Date of Patent: February 14, 2023
    Assignee: Hemanext Inc.
    Inventors: Andrew Dunham, Tatsuro Yoshida
  • Publication number: 20230028174
    Abstract: Methods and compositions for improved clinical outcomes for trauma patients receiving whole blood transfusion. Methods and compositions for improved clinical outcomes for blood transfusions for cancer patients are also provided.
    Type: Application
    Filed: September 27, 2022
    Publication date: January 26, 2023
    Applicant: Hemanext Inc.
    Inventor: Tatsuro YOSHIDA
  • Publication number: 20230015525
    Abstract: Relates to a method for pathogen reduction of a blood product comprising: i) removing oxygen from a blood product; ii) reducing blood pathogens from said blood product t: adding amustaline (S-303) to a final concentration of 0.2 millimolar (mM); and glutathione (GSH) to a concentration of 20 mM; iii) reducing S-303 to a concentration of less than 1 nmol/L comprising incubating said oxygen reduced blood product under oxygen reduced conditions for up to 6 hours; and further relates to a pathogen reduced, oxygen reduced blood product having an oxygen saturation (sO2) of less than 25%, a pCO2 of 90 mmHg or less at 37° C., and having a amustaline (S-303) concentration of less than 1 nmol/L.
    Type: Application
    Filed: October 28, 2020
    Publication date: January 19, 2023
    Applicant: Hemanext Inc.
    Inventors: Jeffrey SUTTON, Tatsuro YOSHIDA, Samuel Q. SOWEMIMO-COKER
  • Publication number: 20220355001
    Abstract: A system and methodology for the preservation of red blood cells is described in which red blood cells are oxygen or oxygen and carbon dioxide depleted, treated and are stored in an anaerobic environment to optimize preparation for transfusion. More particularly, a system and method for extended storage of red blood cells from collection to transfusion that optimizes red blood cells prior to transfusion is described.
    Type: Application
    Filed: July 25, 2022
    Publication date: November 10, 2022
    Applicant: Hemanext Inc.
    Inventors: Tatsuro YOSHIDA, Paul VERNUCCI
  • Publication number: 20220330541
    Abstract: This application provides methods, compositions, and kits for use blood group determination and the preparation of improved red blood cell containing reagents for use in blood typing of blood prior to its use in transfusion medicine.
    Type: Application
    Filed: September 4, 2020
    Publication date: October 20, 2022
    Applicant: Hemanext Inc.
    Inventors: Tatsuro YOSHIDA, Andrew Dunham
  • Publication number: 20220287296
    Abstract: The present disclosure relates to Oxygen Reduction Disposable kits (ORDKit), devices and methods for the improved preservation of whole blood and blood components. The improved devices and methods for the collection of blood and blood components provide for whole blood and blood components having reduced levels of oxygen. The devices and methods provide for the rapid preparation of deoxygenated blood and blood components for storage that improves the overall quality of the transfused blood and improves health outcomes in patients.
    Type: Application
    Filed: May 20, 2022
    Publication date: September 15, 2022
    Applicant: Hemanext Inc.
    Inventors: Michael Wolf, Jancarlo Sarita, Jeffrey Karl Sutton, Rafael Cordero, Michael Zocchi, Philip Keegan, Narendran Renganathan, Robert Harhen
  • Patent number: 11433164
    Abstract: A system and methodology for the preservation of red blood cells is described in which red blood cells are oxygen or oxygen and carbon dioxide depleted, treated and are stored in an anaerobic environment to optimize preparation for transfusion. More particularly, a system and method for extended storage of red blood cells from collection to transfusion that optimizes red blood cells prior to transfusion is described.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: September 6, 2022
    Assignee: Hemanext Inc.
    Inventors: Tatsuro Yoshida, Paul Vernucci
  • Publication number: 20220211030
    Abstract: A blood storage system comprising: a collection vessel for red blood cells; an oxygen or oxygen and carbon dioxide depletion device; a storage vessel for red blood cells; tubing connecting the collection vessel to the oxygen or oxygen and carbon dioxide depletion device and the oxygen or oxygen and carbon dioxide depletion device to the storage vessel; and a gamma or X-ray irradiating device is used to irradiate red blood cells stored in the vessel, storing red blood cells under anaerobic conditions.
    Type: Application
    Filed: March 23, 2022
    Publication date: July 7, 2022
    Applicant: Hemanext Inc.
    Inventors: Tatsura YOSHIDA, Paul VERNUCCI
  • Patent number: 11375709
    Abstract: The present disclosure relates to Oxygen Reduction Disposable kits (ORDKit), devices and methods for the improved preservation of whole blood and blood components. The improved devices and methods for the collection of blood and blood components provide for whole blood and blood components having reduced levels of oxygen. The devices and methods provide for the rapid preparation of deoxygenated blood and blood components for storage that improves the overall quality of the transfused blood and improves health outcomes in patients.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: July 5, 2022
    Assignee: Hemanext Inc.
    Inventors: Michael Wolf, Jancarlo Sarita, Jeffrey Karl Sutton, Rafael Cordero, Michael Zocchi, Philip Keegan, Narendran Renganathan, Robert Harhen
  • Patent number: 11350626
    Abstract: The present disclosure relates to Oxygen Reduction Disposable kits (ORDKit), devices and methods for the improved preservation of whole blood and blood components. The improved devices and methods for the collection of blood and blood components provide for whole blood and blood components having reduced levels of oxygen. The devices and methods provide for the rapid preparation of deoxygenated blood and blood components for storage that improves the overall quality of the transfused blood and improves health outcomes in patients.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: June 7, 2022
    Assignee: Hemanext Inc.
    Inventors: Michael Wolf, Jancarlo Sarita, Jeffrey Karl Sutton, Rafael Cordero, Michael Zocchi, Philip Keegan, Narendran Renganathan, Robert Harhen
  • Publication number: 20220126081
    Abstract: This application provides methods, compositions, and kits for use in removing kinks in tubing.
    Type: Application
    Filed: December 30, 2019
    Publication date: April 28, 2022
    Applicant: Hemanext Inc.
    Inventors: Jeffrey K. Sutton, Austin Lent, George Michaels
  • Publication number: 20220118008
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma. Methods for restoring mean arterial pressure to a normal range and reducing trauma adverse risks in a patient through the administration of oxygen reduced blood compositions.
    Type: Application
    Filed: June 4, 2021
    Publication date: April 21, 2022
    Applicant: Hemanext Inc.
    Inventors: Andrew DUNHAM, Tatsuro YOSHIDA
  • Patent number: D961765
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: August 23, 2022
    Assignee: Hemanext Inc.
    Inventors: Janearlo Sarita, Rafael Cordero, Jeffrey Sutton, Michael Zocchi, Ayan Bhandari, David Copeland